Clinical Predictors Of Cognitive Impairment And Psychiatric Complications In Parkinson's Disease.

dc.creatorCampos, Lidiane S
dc.creatorGuimarães, Rachel P
dc.creatorPiovesana, Luiza G
dc.creatorAzevedo, Paula C de
dc.creatorSantos, Leonilda M B
dc.creatorD'Abreu, Anelyssa
dc.date2015-May
dc.date2016-05-23T19:42:36Z
dc.date2016-05-23T19:42:36Z
dc.date.accessioned2018-03-29T01:29:51Z
dc.date.available2018-03-29T01:29:51Z
dc.identifierArquivos De Neuro-psiquiatria. v. 73, n. 5, p. 390-395, 2015-May.
dc.identifier1678-4227
dc.identifier10.1590/0004-282X20150016
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/26017203
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/235782
dc.identifier26017203
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1304025
dc.descriptionTo estimate the clinical and demographics aspects that may contribute to cognitive impairment and psychiatric symptoms in Parkinson's disease (PD). All patients answered a structured standardized clinical questionnaire. Two movement disorders specialists performed the following scale: Unified Parkinson's disease rating score (UPDRS), the modified Hoehn and Yahr staging, Schwab and England Scale, SCOPA cognition (SCOPA-COG), SCOPA-Psychiatric complications (SCOPA-PC) and Non-Motor Symptoms Scale (NMSS). We built a generalized linear model to assess predictors for the SCOPA-COG and SCOPA-PC scores. Almost 37% of our patients were demented as per SCOPA-COG scores. Level of education and the UPDRS-Subscale III were predictors of cognitive impairment. Higher scores in domain 3 of NMSS and male gender were associated with psychiatric complications as assessed per the SCOPA-PC. Level of education and disease severity are predictors of dementia in PD. Psychiatric complications are more commonly observed in men.
dc.description73
dc.description390-395
dc.languageeng
dc.relationArquivos De Neuro-psiquiatria
dc.relationArq Neuropsiquiatr
dc.rightsfechado
dc.sourcePubMed
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 And Over
dc.subjectAntiparkinson Agents
dc.subjectCognition
dc.subjectCognition Disorders
dc.subjectEducational Status
dc.subjectEpidemiologic Methods
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMental Disorders
dc.subjectMiddle Aged
dc.subjectNeuropsychological Tests
dc.subjectParkinson Disease
dc.subjectPsychiatric Status Rating Scales
dc.subjectPsychometrics
dc.subjectRisk Factors
dc.subjectSeverity Of Illness Index
dc.subjectSex Factors
dc.titleClinical Predictors Of Cognitive Impairment And Psychiatric Complications In Parkinson's Disease.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución